Arkolith/Insider Trading/JBIO/Form 4

Fairmount Healthcare Fund II L.P.

Director, 10% OwnerJade Biosciences, Inc. (JBIO) · full profile →Form 4 · filed Oct 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)1.3M$9.14$12.2M1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)855K$9.14$7.8M855K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-097921) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML